Naturally occurring polyamine · Fact sheet
Spermidine
Also known as dietary spermidine · polyamine
Spermidine is a real cellular metabolite and a plausible autophagy research target, but it is not an FDA-approved drug for cognitive decline or aging. A 12-month randomized trial in older adults did not improve its primary memory outcome.
What is Spermidine?
Spermidine is a polyamine involved in cell growth, protein function, and cellular maintenance. It occurs in human cells and in foods.
Laboratory and animal findings connect spermidine with autophagy and lifespan biology, but those findings do not establish a human anti-aging effect.
Benefits people look for
Autophagy is a core cellular recycling process, and dietary observational studies have linked higher spermidine intake with some favorable outcomes.
Observational diet patterns can carry many confounders, so randomized trials are essential.
What the evidence supports
- A small pilot generated a possible memory signal that justified a larger trial.
- The larger SmartAge trial did not confirm a significant improvement in the primary memory outcome, although exploratory biomarker work continues.
All research areas
- Memory in subjective cognitive decline
- Autophagy-related biomarkers
- Cardiometabolic and healthy-aging associations
- Dietary polyamine biology
Anecdotal reports & lived experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens.
No attributable personal reports are summarized here yet. The benefits above describe research interests; the side effects below come from the cited medical sources.
We do not fill this gap with unsourced testimonials or estimated success rates.
Side effects & risks
- The studied food-extract formulation was generally tolerated, but available trials are not large enough for uncommon harms.
- A supplement extract is not interchangeable with dietary intake or endogenous spermidine biology.
- Commercial product composition and labeling may vary.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research: how strong is it?
Early human evidenceHuman observational evidence and small trials generated interest, but the phase 2b SmartAge trial did not show a significant benefit on its primary memory endpoint after 12 months.
Selected research to read
Phase 2b trial reporting no significant improvement in its primary memory endpoint.
Prospective protocol defining the trial design and planned cognitive outcomes.
Peer-reviewed mechanistic review that helps separate biological rationale from clinical proof.
FDA approval & research status
Spermidine is not an FDA-approved drug for memory, cognitive decline, dementia prevention, autophagy enhancement, or aging. Dietary supplements are not preapproved by FDA for effectiveness.
No FDA-approved use is documented in the records summarized on this page.
No FDA-approved cognitive or aging use
Spermidine has dietary and supplement research, including a negative primary memory outcome in a Phase 2b cognitive trial, but no FDA-approved drug use.
This summarizes the cited product or research record. Trial phases do not establish successful completion of earlier stages, and a stopped program is not ongoing development. Approval applies only to the labeled product, use and population.
What we still don’t know
- Whether another population or outcome would show a reproducible benefit
- Whether supplement exposure meaningfully changes autophagy in relevant human tissues
- Long-term safety and interaction effects
- Whether observational diet associations are causal
The takeaway
Spermidine is mechanistically interesting, but the best cognitive trial so far was negative on its primary outcome. That is a reason for better research, not a benefit claim.
Sources & further reading
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- 1pubmedSmartAge randomized clinical trial
Phase 2b trial reporting no significant improvement in its primary memory endpoint.
- 2pubmedSmartAge trial protocol
Prospective protocol defining the trial design and planned cognitive outcomes.
- 3pubmedMechanisms of spermidine-related autophagy research
Peer-reviewed mechanistic review that helps separate biological rationale from clinical proof.
- 4fdaFDA: what ‘FDA approved’ does and does not mean
FDA explains that dietary supplements are not approved for safety and effectiveness before marketing.